大綱了解醫療疏失發生的原因為何?(System Theory)探討如何有效防範醫療疏失?用藥安全監測錯誤防範機制就醫比搭飛機安全?每兩天,掉三架巨無霸客機的死亡人數在美國每年因醫
REM ●定义-内异症患者经手术或有规则药物治疗后,症状体征已消失,评价已治愈,但经过几个月(3个月)症状、体征重又出现●主要问题-疼痛,包块,不孕·发生率-6.1％-40％REM发病率·
卒中是人类的第二位死因,在中国为首位死因.我国现存卒中患者超过700万,居血管性疾病之首[1-4].每年新发病例100万～200万,校正年龄后卒中年发病率为(116～219) /10万,年死亡率为
Objective: The prognostic significance of O6-methylguanine-DNA methyltransferase (MGMT) promoter status for survival of patients with malignant gliomas rema
目的：鼻腔副鼻窦恶性黑色素瘤发病率低，预后差。鼻腔副鼻窦恶性黑色素瘤以手术治疗为主，放疗的报道较少，其作用仍有争议。本文回顾性分析原发鼻腔副鼻窦恶性黑色素瘤52例，探讨
Objective: Esthesioneuroblastoma (ENB) is a rare malignant neoplasm with great controversies on management of the neck.The aim of this study is to character
目的：探讨术后131I治疗前刺激性甲状腺球蛋白(ps-Tg)＜ 10ng/ml的非远处转移性分化型甲状腺癌(DTC)患者经131I治疗后的临床转归，以及ps-Tg对DTC患者临床转归的预测价值.方法：2
Objective: Amplifications and activating mutations in the c-MET proto-oncogene are known oncogenic drivers that have proven responsive to targeted therapy.
Objective: Nivo, a fully human IgG4 PD-1 immune checkpoint inhibitor antibody, has demonstrated durable responses and tolerability in heavily pretreated pat
Objective: Nivo, a fully human IgG4 programmed death-1 immune checkpoint inhibitor antibody, has demonstrated durable responses and tolerability in heavily